This hottest twist while in the Lykos Therapeutics saga threatens An important overhaul of the corporation’s strategy and course, with Musk ally and billionaire investor Antonio Gracias appearing to choose to choose the corporate again towards its nonprofit drug improvement roots and a more Doblinite philosophy.In lots of respects, the for-financ